PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

AnPac Bio-Medical Science Co., Ltd.

USPTO PatentsView assignee record - 14 granted patents across 8 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Anpac ranks #19,448 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 8 technology areas.

#19,448
of 49,997 US assignees by volume
Top 41%
by Innovation Score (38.4/100)
35.1
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19448 · Foreign Corporation #19,448 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #19,448/49,997
  • PHOTO-FINISH Ameranth
  • CPC-NARROW B01L · 8 areas
  • INNOV-THIN 38.4/100
  • CLAIMS-DENSE 35.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ameranth, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Anpac’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Anpac

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Anpac's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Anpac?

Each dot is one of Anpac’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Anpac’s own 35.1 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Anpac vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 010203040 Granted patents (volume) Avg claims / patent Ameranth, Inc. - 14, 17.43AmeranthAmerican Teleconferencing Services, Ltd. - 14, 17.14American Teleconf…Amesite Inc. - 14, 13.5AmesiteAmylin Pharmaceuticals, LLC - 14, 11.64Amylin Pharmaceut…Andrew LLC - 14, 22.14AndrewAneuclose LLC - 14, 5.57AneucloseAnji Henglin Technology Development Co., Ltd. - 14, 1Anji Henglin Tech…Aon Global Operations SE, Singapore Branch - 14, 18.5Aon Global Operat…AnPac Bio-Medical Science Co., Ltd. - 14, 35.07Anpac Bio-medical…
Anpac vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Anpac's grants concentrate

AnPac Bio-Medical Science Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 85.7% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2019. By volume, Anpac sits between Ameranth, Inc. and Aon Global Operations SE, Singapore Branch.

Anpac's three-year grant acceleration

AnPac Bio-Medical Science Co., Ltd. shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at AnPac's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows AnPac holds 14 patents at rank #19,468, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near AnPac

By rank, the assignees closest to #19,468 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in AnPac's primary technology class.

Anpac's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201720182019202020212022 3
USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
AnPac Bio-Medical Science Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 14.3%
2018 4 28.6%
2019 1 7.1%
2020 2 14.3%
2021 2 14.3%
2022 3 21.4%

Which technologies does AnPac Bio-Medical Science Co., Ltd. patent most?

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AnPac Bio-Medical Science Co., Ltd.'s patent record in context - here's where to go next.

  • AnPac Bio-Medical Science Co., Ltd.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 85.7% of its portfolio - see every assignee active in that class. Explore B01L
  • Ranked #19,448 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare AnPac Bio-Medical Science Co., Ltd. against Ameranth, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.